Document is current
Any future updates will be listed below
-
Authors
Staubo, Sara C.
Fuskevåg, Ole Martin
Toft, Mathias
Lie, Ingeborg H.
Alvik, Kirsti M. J.
Jostad, Pål
Tingvoll, Stein H.
Lilleng, Hallvard
Rosqvist, Kristina
Størset, Elisabet
Odin, Per
Dietrichs, Espen https://orcid.org/0000-0002-3328-5263
Dietrichs, Erik Sveberg
-
Funding
Funding for this research was provided by:
Reberg's Trust for Parkinson Research
University of Oslo
- License Information
-
More Information
Article History
Received: 11 November 2024
Revised: 13 December 2024
Accepted: 16 December 2024
First Online: 15 January 2025
Declarations
:
: All authors declare no financial or non-financial competing interests related to this study. Not related to this study: Per Odin has given lectures and/or been advisor with honorarium for AbbVie, Bial, Britannia, Global Kinetics, Lobsor, Lundbeck, Nordic Infucare, Stada, UCB and Zambon, and has participated as an investigator in clinical studies performed by AbbVie, Global Kinetics, IRL, UCB and Zambon. Espen Dietrichs has given lectures and/or been advisor with honorarium for AbbVie, Global Kinetics, Ipsen and Nordic Infucare. The other authors have nothing to declare.
: The study was approved by the Personvernombudet/Datatilsynet (General Data Protection Regulation in Norway; reference: 2018/6255), the Regional Ethical Committee in Northern Norway (reference: 2018/1343/REK nord), and the Swedish Ethical Board (reference: 2022–01340-01). Written informed consent was obtained from each study participant before inclusion.
